About Curio Bioscience
Curio Bioscience is a Healthcare company based in Palo Alto (United States) founded in 2021 by Christina Fan, Ari Chaney, and Stephen Fodor, and was acquired by Takara Bio in January 2025. Spatial omics solutions are provided for discovery research. Its chief executive, as recorded, is Stephen Fodor. Curio Bioscience offers products and services including Seeker and Trekker. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Informatics. Its competitors include Cellworks, Genuity Science and Codetta; 3 of its 3 listed competitors have raised funding.
Company details
Curio Bioscience was founded in 2021 and is based in Palo Alto, United States. Spatial omics solutions are offered for discovery research within the biotechnology sector. Products including the Curio Seeker bioinformatics pipeline are provided to support spatial transcriptomics analysis. High-resolution mapping is enabled through these tools, by which insights into complex cellular biology are uncovered by researchers.
- Headquarters Palo Alto, United States
- Founders Christina Fan, Ari Chaney, Stephen Fodor
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website curiobioscience.com
- Social LinkedIn X Facebook
- Acquired by Takara Bio (Jan 2025)
- Latest Funding Round$2M (USD), Grant
Mar 2022
- InvestorsHHS
& 1 more
- Acquired byTakara Bio
(Jan 2025)
Products & Services of Curio Bioscience
Curio Bioscience offers a comprehensive portfolio of products and services, including Seeker and Trekker.
Provides high-resolution RNA expression mapping for fresh frozen tissues.
Enables single-cell analysis with spatial orientation for genomics research.
Funding Insights of Curio Bioscience
- Total Rounds 1
- Last Round Grant — $2M
- First Round $2M
(Mar 2022)
- Investors Count 1
All 1 funding rounds of Curio Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2022 | $2M | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Curio Bioscience
Curio Bioscience has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Takara Bio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Developer of gene-based therapies as well as contract services for the industrial and agricultural sector | 1925 | takara-bio.com | Frankfurt, Germany |
Investor details for Curio Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Curio Bioscience
3 people are tracked at Curio Bioscience (3 in leadership).
| Name | Role | Group |
|---|---|---|
Christina Fan | Co-Founder & CTO | Leadership |
Ari Chaney | Co-Founder & COO | Leadership |
Stephen Fodor | Co-Founder & CEO | Leadership |
Complete people profiles for Curio Bioscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Curio Bioscience
3 dated milestones of Curio Bioscience across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Curio Bioscience is founded.
- Funding First funding round of $2.0M.
- Exit Acquired by Takara Bio.
Competitors of Curio Bioscience
Curio Bioscience has 3 listed competitors in our database, 3 of them funded. They include Cellworks, Genuity Science and Codetta.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cellworks.life | 2005 | San Jose, United States | $16.52M | Biosimulation platform developed for therapeutic design in life sciences. | ||
| genuitysci.com | 2013 | Boston, United States | $515M | AI-based omics data analysis solutions are provided to researchers. | ||
| codettabio.com | 2021 | Morrisville, United States | $27.28M | Omics clinical data is analyzed through an online platform. |
Detailed competitors of Curio Bioscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Curio Bioscience
The website of Curio Bioscience (curiobioscience.com) receives about 4.7K visits a month.
- Monthly visits4.7K
▲ 36.6% vs previous month
Websites whose visitors overlap most with Curio Bioscience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
takarabio.com | takarabio.com | 100% | #267,918 | – |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Curio Bioscience (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Curio Bioscience
Complete news archive for Curio Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Curio Bioscience
Curio Bioscience was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Curio Bioscience is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Stephen Fodor is the CEO of Curio Bioscience, as recorded in our data. They have also founded this company.
Curio Bioscience was founded in 2021 and is based in Palo Alto, United States. Spatial omics solutions are offered for discovery research within the biotechnology sector. Products including the Curio Seeker bioinformatics pipeline are provided to support spatial transcriptomics analysis. High-resolution mapping is enabled through these tools, by which insights into complex cellular biology are uncovered by researchers.
Curio Bioscience's top competitors include Cellworks, Codetta and Genuity Science.
Curio Bioscience offers Seeker and Trekker.
Curio Bioscience has 2 investors. Key investors include HHS, and Takara Bio.
Yes. Curio Bioscience was acquired by Takara Bio in January 2025.